MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is MYDX's CannaDX product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
That is not my quote, not sure what you are asking either.
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
FACTS are in FAVOR of MYDX
I'm, that's called investors buying and holding, investors know what they are holding. Prices fluctuate all the time in the market. Strategic trading can give the perception of pump and dump because that's easier to believe. That's not the case with MYDX.
The reason sp shot up 10x was because of new investors. The reason it's at double zero is because investors aren't selling 2017, the reason it's not triple zero is because investors aren't selling and are accumulating as they can, and the reason it will shoot up most likely at least 10x is because of new investors with new confidence in MYDX.
Trends change but now that's it's reaching stability, time to fly!
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
https://www.google.com/amp/s/amp.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona Why would Big Pharma want to stop something they don't care to get into?
Yep, it's all about cannabis research and research is in Canada and Canada is ahead of US in cannabis research and MYDX is laying a solid foundation in the country that is the forefront of all the research. Great strategy by MYDX:
https://www.leafly.com/news/science-tech/medical-marijuana-research-from-canadian-producers
Of course, US is also researching cannabis but who knows when it will create policy for legalization.
MYDX is taking all the risk because large corporations can just buy their way in:
https://www.google.com/amp/s/www.greenrushdaily.com/apple-not-developing-ivape-vaporizer/amp/
Looks like this tech giant will be billions away and years behind MYDX like other tech giants who don't want to risk what MYDX is already in the process of doing and has already accomplished by creating a company that is selling cannabis related products and becoming cash flow positive. This company will continue to update the public on topics that are important for people to know, for people who want to live a better life. MYDX is the solution and other companies will have to go through MYDX.
How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already?
How many big pharma companies are developing a medicinal marijuana vape pen that communicates to a device that can be used by doctors to help aid in prescribing remedies for their patients? Is it because they already know MYDX is doing it and is planning on releasing the product to the market by end of year? Are big pharma not taking the risk because they know they can just buy their way into MYDX and go through MYDX? How will all this affect current shareholders?
This topic has already been around a good while and will only intensify as countdown progresses to Canadian legalization and MYDX having a foothold in Canada will be a seamless entry into US households not to mention it has continued building an investment shareholder presence which is rare in OTC:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
Sp is not a factor in the equation, it is the end result of the factors and investors are just one of the factors. Soon, investors will be an effective factor again driving the price over .01
In fact, isn't it common knowledge that it is recommended that investors consider companies that are not trading in the OTC? I believe MYDX is one of the probably fewer than 1% trading on the OTC that will trade on NASDAQ in under 5 years. Investors climbed a mountain in March. Charts don't reveal any period of time where traders jumped the cliff. It appears very much to be a slow and gradual period of low trading volume at which currently new investors will be climbing a new mountain at a higher starting elevation. This will be the continuing trend for the next 5 years.
Ultimately, it should be the responsibility of the consumer to "trust & verify" what is already known to be a flawed mass production mentality. There is always a margin of error and now consumers will have the ability to adjust this margin of error by identifying it with MYDX products.
We all know it's a simple equation with complex factors. Investors are far from being the only factor.
We'll see what investors have to say about it.
I believe you're on wrong track, company has proven the product enough for customer growth with increased data increasing the overall value of MYDX 360 every day and with Canada marketing campaign, it is all coming together. Investors will be buying in in a huge way which will bring the market cap up to a reasonable $100million by end of year 2017 and sp should be at least .10 at that time. Very possible and I believe to be a conservative estimate. Also, financials will continue to improve.
I happen to know that weed can make me dizzy, like vertigo and that makes me nauseous which makes me vomit. "Mystery strain" because I was at a party when I had it. Apparently, weed is not just weed, I have smoked some really good stuff. I never want to feel what put me on that floor vomiting for what seemed to be an eternity and MYDX's CannaDX is the solution.
I know for a fact that is FALSE but by all means, please don't take my word for it. There are many who will agree, not just today, but for years and beyond.
Having had the CannaDX will save me hours of priceless hours on the floor vomiting and steer me toward the cannabis I desire and away from the "nightmare" I label the mystery strain, a mystery no more.
Yes, great article, this is exactly what I envision and I'm sure what will be at the very least what "Powered By MYDX" will mean to doctors looking for an outlet to prescribe a cannabis medicine to desired patient's needs through the MYDX medicinal cannabis vape pen.
MYDX medicinal vape pen will actually offer MORE than vape pens currently sold and that the feedback system of the pen communicating to the smart device. That is one major "one up" on current market.
I trust testimonies of consumers who have bought and used the device on a regular basis and I do not trust speculators who do not own the product or use on a regular basis that claim the product is junk or a toy.
Consumer confidence will only grow with testimonies from actual product users, good or bad. Consumer confidence, good or bad, is what really matters to someone considering to buy a product. It's a very curious product. Anyone wanting to satisfy their curiosity will have to buy the product. More consumers than not, I believe will be verifying that the product works the way it's supposed to work.
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
According to the majority of reviews, CannaDX is reliable and appreciated and a great source for anyone considering to purchase. Anyone curious about the product will have to buy it to determine its reliability for them.
MYDX Conservative estimate: MYDX market cap of $100 million by end of year 2017. It is reasonable and likely with this market cap, MYDX will be trading at .10+ by end of year 2017.
That one obviously isn't reliable. This isn't a slot machine company.
June 26, 2017 latest app update, MYDX listens and responds.
Excellent, great find! I found this link through yours. (Link to follow) Word is gettig around about MYDX's CannaDX, check the reviews out:
https://www.amazon.com/gp/aw/cr/B01DCGHX80/ref=cm_cr_getr_mb_paging_btm_2?reviewerType=all_reviews&pageNumber=2
And these are reviews just from this vendor. Plus, many events happening starting July in Canada do your own DD, MYDX will be all over Canada in the months to come!!
This topic will only intensify each day from now on as countdown progresses to Canadian legalization and MYDX having a foothold in Canada will be a seamless entry into US households not to mention it has continued building an investment shareholder presence which is rare in OTC:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Another source stating US is falling behind: https://www.google.com/amp/s/www.fool.com/amp/investing/2017/06/30/forget-the-us-marijuana-market-there-are-big-oppor.aspx
Looks like MYDX is marketing in currently the best market. Smart move by MYDX and Company.
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
Another source stating US is falling behind: https://www.google.com/amp/s/www.fool.com/amp/investing/2017/06/30/forget-the-us-marijuana-market-there-are-big-oppor.aspx
Looks like MYDX is marketing in currently the best market. Smart move by MYDX and Company.
https://finance.yahoo.com/news/mydx-supports-product-sales-torontos-130000597.html?.tsrc=applewf
"The primary objective of MyDx's business development and market awareness efforts is to help people Trust & Verify® their consumption habits with CannaDxTM, consider alternative delivery Smart Devices like the MyDx ECO Smart PenTM that has the potential to limit abuse and enhance safer use, and leverage the MYDX 360TM service to support access to crowdsourced formulation data for new market entrants, Canadian biopharmaceutical companies and licensed growers."
Looks like MYDX already has its sights set on Canadian biopharma. Looks like this is just the beginning for MYDX to offer licensing deals with biopharma that will eventually be doing the same in US after gaining a foothold in Canada since big pharma didn't in US didn't want to take the risk, they can just buy into MYDX.
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
https://www.google.com/amp/s/amp.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona Why would Big Pharma want to stop something they don't care to get into?
Yep, it's all about cannabis research and research is in Canada and Canada is ahead of US in cannabis research and MYDX is laying a solid foundation in the country that is the forefront of all the research. Great strategy by MYDX:
https://www.leafly.com/news/science-tech/medical-marijuana-research-from-canadian-producers
Of course, US is also researching cannabis but who knows when it will create policy for legalization.
MYDX is taking all the risk because large corporations can just buy their way in:
https://www.google.com/amp/s/www.greenrushdaily.com/apple-not-developing-ivape-vaporizer/amp/
Looks like this tech giant will be billions away and years behind MYDX like other tech giants who don't want to risk what MYDX is already in the process of doing and has already accomplished by creating a company that is selling cannabis related products and becoming cash flow positive. This company will continue to update the public on topics that are important for people to know, for people who want to live a better life. MYDX is the solution and other companies will have to go through MYDX.
How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already?
https://news.vice.com/story/the-canadian-marijuana-industry-is-facing-a-supply-crunch
Quote:
"There are currently 45 licensed producers (LPs) of medical marijuana in Canada, and 428 others in line to become LPs. These 45 existing LPs sustain a $400 million market of 153,000 medical marijuana patients, a number that has doubled in just one year, and continues to grow at a rapid pace."
MYDX said in its latest PR that it is finding licensed growers to partner with (link to follow) and with over 150,000 medical marijuana patients and MYDX 360 continuing to increase in value, not only will MYDX be working with Canadian growers but doctors prescribing treatments through the licensing of the MYDX medicinal vape pen "Powered By MYDX":
"Over the next several months, we will initially focus on big box Canadian retailers and seek partners with a solid network of licensed growers."
https://finance.yahoo.com/news/mydx-supports-product-sales-torontos-130000597.html?.tsrc=applewf
People won't be turning their backs to a company proving to help people live a better life. CannaDX is just the beginning. Soon, MYDX will release all the sensors to help people put in their bodies what they intended and it communicates via Bluetooth to acquire data to improve effectiveness and communicate to others who seek similar therapies. All are welcome to buy products and invest in the product they believe in and know it's not going anywhere but UP.
It says to people, "Here's a product that helps people live a better life AND here's where investors go to support the company that helps people live a better life." BRAVO MYDX AND COMPANY!!! and a personal thank you to MYDX for helping me live a better life.
They being the investors just now finding out about MYDX with strong marketing campaign. Usually they don't look at OTC but it sure is hard not to see MYDX now.
They would have to since their brokerage doesn't trade subpenny.
All about the vision if an investor wants to have an edge before other investors. Many are waiting for .01 to buy in. This is going to be HUGE.
I would double down on that deal but I'm a serious investor like many and my brokerage doesn't trade subpenny unlike many.
I agree, accurate interpretation of financials are important. MYDX is improving and strengthening and is showing no signs of slowing down, which translates nicely to investors who are taking an OTC risk.
Financials specs LACK vision. Those things currently don't matter to investors. Investors have vision and they know where MYDX is headed.
A lot of serious investors who don't normally seek out OTC but see and hear about MYDX and do all the necessary DD and agree that investing in MYDX is a no-brainer GO but their brokerage doesn't trade subpenny are ALL waiting for .01 and when that happens, because of how long the sp has been subpenny will skyrocket buyer urgency at .01 and we will see 100s possibly even 1,000s of millions of shares fighting for the best position and that is why investors are saying .10 by end of 2017 and .25 by this time 2018. MYDX is a no-brainer GO after ALL DD. MYDX is the PREMIER HOUSEHOLD CANNABIS PRODUCT. Where's the competition. What other company is acquiring the data MYDX is? You can't do that without an accessible product.
The longer MYDX sits subpenny, the more time to accumulate investors sitting at .01with thousands of dollars to buy in. All that adds up to expectations.
Ha! Selloff? Same shares keep trading same hands trying to take MYDX down. Along the way investors are accumulating and will drive price way high with demand. It's only a matter of time. Soon will be the days of 100s of millions not 10s of millions. MYDX is a serious player in the OTC. It won't stay this low for long. Urgency will kick in and its back to multipennies.
Progress is in the works, vision isn't seeing what is, it's EVERYTHING affected by many factors. Sp will be great for investors ROI. No selling 2017.